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Cardiovascular 
magnetic resonance in 
endomyocardial fi brosis
the study included patients with early, subclinical disease.(2) 
Clinical presentation is characterised by a bimodal peak at the 
ages of 10 and 30 years, respectively.(3) Pathologically, there is 
fibrosis of the RV and/or LV apical endocardial surfaces that 
leads to restrictive physiology. Furthermore, tethering of the 
atrioventricular (AV) valve papillary muscles and/or  fibrosis of 
the respective ventricular inflow tracts leads to significant AV 
valve regurgitation. Gross pathology reveals ventricular endo-
cardial thickening and fibrosis often with overlying thrombus. 
The atrium of the affected ventricle is often dramatically 
enlarged, with reduced ventricular volumes. Histopathology 
demonstrates increased type I collagen deposition, subendo-
cardial infarction, fibrosis, and thrombus.(4) On pathological 
examination, there is a lack of inflammation or eosinophilia, 
implying that at end-stage disease, the inflammatory process 
is inactive.(5) 
Cardiovascular magnetic resonance (CMR) is well suited to 
address the early diagnosis, clinical follow up and surgical 
planning in EMF. Pathological and haemodynamic features 
of the disease can be identified easily by CMR. These include 
LV function, presence of thrombus, inflammation, regurgitant 
valves, diastolic dysfunction and presence of fibrosis (late 
gadolinium enhancement – LGE). 
CASE REPORT
We report on a 35-year-old man, who was previously well 
with no medical comorbidity and no prior hospitalisation. He 
was physically active with an excellent performance status and 
has never travelled outside of the Western Cape Province. 
He is married with 1 child and employed as a security officer. 
ABSTRACT
Endomyocardial fi brosis (EMF) is an idiopathic disorder 
of the tropical and subtropical regions of the world, 
considered endemic in tropical and subtropical Africa 
and is characterised by development of restrictive car-
diomyopathy. Although accurate epidemiological data 
are lacking, EMF is estimated to be the most common 
form of restrictive cardiomyopathy globally. We report 
on a young patient presenting with a stroke diagnosed 
with EMF and review the role of cardiovascular magnetic 
resonance in evaluation of EMF.  SAHeart 2020;17:214-216
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INTRODUCTION
Endomyocardial fibrosis (EMF) is an idiopathic disorder of 
the tropical and subtropical regions of the world, considered 
endemic in tropical and subtropical Africa and is characterised 
by development of restrictive cardiomyopathy. First described 
in 1948 by John Davies in Uganda, it is typically a disease asso-
ciated with rural poverty and is typified by fibrosis of the apical 
endocardium of the right ventricle (RV), left ventricle (LV), or 
both. The clinical manifestations are largely related to the con-
sequences of restrictive ventricular filling, valvular regurgita-
tion, arrhythmias, embolic phenomena and cardiomyopathy, 
including left- and right-sided heart failure.(1) The prognosis is 
poor in advanced disease. 
Although accurate epidemiologic data are lacking, EMF is 
estimated to be the most common form of restrictive cardio-
myopathy globally. An echocardiographic screening study in 
Mozambique found a population prevalence of 20%, though 
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He collapsed while in duty at 02h00 in the morning. He claims 
he did not lose consciousness but was unable to stand 
because of acute onset weakness in the right arm and leg. He 
was discovered by his colleagues while lying on the ground 
and brought by ambulance to the emergency unit at Groote 
Schuur Hospital. On arrival, his Glasgow Coma Score was 
15/15 and he had an obvious left 7th cranial nerve palsy, slur-
ring of his speech and a dense right-sided hemiplegia. He 
FIGURE 1: Cardiovascular magnetic resonance features of endomyocardial fibrosis. 
(A) Balanced steady state free precession (bSSFP) horizontal long axis (HLA) view showing dilated left ventricle (LV), biatrial enlargement – left 
atrium (LA) with white asterix and right atrium (RA) with yellow asterix, obliterated apex with filling defect and thickened, retracted papillary 
muscles, as well as the classical V sign on top of the apical filling. In addition, there is partial atelectasis of the right lung (red arrow), with 
bilateral pleural effusions, bigger on the right (white arrow); (B) Cine tagging image showing that the apical filling in the LV apex was adherent 
to the myocardium and did not move independently, as well as confirming severe diastolic dysfunction and strain impairment; (C) bSSFP 
vertical long axis view showing the C-shaped basal segments of the LV wall (orange arrows) with a bowl-shaped configuration of the proximal 
LV, a dilated LA, and a collapsed right lung and a moderately sized right-sided pleural effusion (white arrow); (D) bSSFP left ventricular outflow 
tract (LVOT) view showing an obliterated apex with a V sign above the filled apex (purple arrow) and a dilated LA; (E) short-axis (SA) stack 
showing a dilated LV, a small pericardial effusion (green arrow), obliteration of the apex below the papillary muscles (yellow arrow), and a 
small amount of ascites (blue arrow); (F) T2 mapping showing absence of myocardial oedema/inflammation (T2 46 ms); (G) native T1 mapping 
showing elevated T1 time (T1 1376ms); (H) postcontrast T1 image, with extracellular volume  value of 37%; (I) LGE HLA image showing 
subendocardial enhancement (white arrow) and calcified thrombus in the LV apex and the classical bowl-shaped proximal portion of the LV. 
In addition, the thin walls of the LA also enhance; (J) LGE LVOT view showing a classical V sign in LV apex; (K) LGE (SA) stack showing 
enhancement of the papillary muscles (red arrows) and a small pericardial effusion; and (L) LGE VLA view showing the classical V sign at the 
apex and the subendocardial enhancement. 
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was also diagnosed with heart failure. His electrocardiogram 
showed frequent ventricular ectopy but was otherwise unre-
markable and a brain computed tomogram confirmed a left 
middle cerebral artery infarct. His full blood count and renal 
function were normal. There was no eosinophilia in his differ-
ential white blood cell count. The next morning, he had an 
echocardiogram that revealed severe LV systolic dysfunction, 
LV ejection fraction (LVEF) of 30% and obliteration of his LV 
apex, with severe diastolic dysfunction and severe mitral and 
tricuspid regurgitation. A provisional diagnosis of EMF was 
made, and he was referred for CMR. 
CMR (Figure 1) confirmed mildly increased LV volumes (LV 
EDV 208mL; LVESV 144mL). He had severely impaired LV 
systolic function (LVEF 31%) and marked global hypokinesia 
of all LV segments. There was no LV hypertrophy. The apex 
was akinetic and there was a filling defect in the apex of the 
LV. The tissue characteristics were in keeping with calcified 
thrombus. The LV walls had normal thickness. There was 
marked increased left atrial size (66mm in the 3-chamber view; 
area 74.8cm2). There were intact interventricular and inter-
atrial septae. He had severe mitral regurgitation, with a mitral 
valve that opened normally, and with thin mobile leaflets. There 
was a tricuspid aortic valve, which opened normally, with mild 
aortic regurgitation and normal aortic dimensions. The RV 
volumes were mildly increased, with moderate impairment in 
RV systolic function (RVEF 39%). There was no RV hyper-
trophy. The right atrium was moderately increased (area 
36.3cm2). He had normal tricuspid valve morphology and 
severe tricuspid regurgitation and a central jet of mild pul-
monic regurgitation. He had a mildly dilated right ventricular 
outflow tract (31mm) and a dilated pulmonary artery (38mm). 
On T1- and T2-weighted images, there was no myocardial 
oedema. On parametric mapping, he had a normal T2 time 
(46ms), but an elevated native T1 time (1 376ms) as well as 
an elevated extracellular volume fraction (37%). On LGE 
imaging, there was subendocardial enhancement of the LV, 
with large apical thrombus that enhanced in the classical V 
shape, and fine, patchy enhancement in the myocardium and 
apex. Of note, the thin walls of the dilated left atrium also 
took up contrast. Both papillary muscles also enhanced. There 
was no RV enhancement. The pericardium was normal in 
thickness with a small effusion (12mm). The lungs showed 
moderate bilateral pleural effusions, partial collapse of the right 
lung and bilateral pulmonary interstitial infiltration in keeping 
with pulmonary oedema and upper lobe venous diversion.
The patient was treated for heart failure and had almost 
complete resolution of his neurological deficit. His Holter 
monitoring has failed to show atrial fibrillation or atrial flutter. 
He continues to work as a security guard and follows up at the 
cardiomyopathy specialist clinic. 
DISCUSSION
CMR lends itself to comprehensive evaluation of EMF. Balanced 
steady state free precession imaging is ideal for assessment of 
LV and RV volumes, mass and function as well as pleural and 
pericardial effusions and the presence of extra-cardiac masses. 
In addition, these sequences are useful for the evaluation of 
typical features of EMF including biatrial dilatation, a V sign 
(cased by layered thrombus) in the apex, filling and obliteration 
of the LV (and RV) apex, and basal segments of the LV that 
appear like a bowl (or 2 C’s facing each other). Parametric 
mapping may be used to assess for acute myocardial oedema 
or inflammation in the acute phase as well as the presence 
of diffuse fibrosis and expanded interstitial matrix. LGE imaging 
is important for assessment of focal fibrosis in the myocar-
dium, as well as a typical subendocardial pattern or so-called 
Zebra pattern secondary to layered overlying thrombus. The 
fibrotic may extend to the subvalvular plane, with involvement 
of papillary muscles, and retraction of the apex. Regurgitant 
lesions of the valves, as in this case, are common and occur 
because of fibrosis of the subvalvular apparatus causing restric-
tion of the posterior mitral leaflet on the left side and the 
posterior aspect of the tricuspid valve on the right side.(6-8)
CONCLUSIONS
CMR is a useful imaging tool for diagnosis of EMF, for risk 
stratification, and for planning of surgery and may be used at 
every stage of the disease. 
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